Acquisitions

3 Months Ended

Mar. 31, 2013

Acquisitions

Acquisitions

2. Acquisitions

In March 2012, the Company completed the acquisition of SkyScan N.V. (the “SkyScan business”), a privately owned company based in Belgium that provides advanced, high-resolution micro-computed tomography systems for three-dimensional X-ray imaging in preclinical imaging applications and materials research markets.  The Company expects synergies from combining the SkyScan business into its current product portfolio. The acquisition of the SkyScan business has been accounted for under the acquisition method.  The components and fair value allocation of the consideration transferred in connection with the SkyScan business are as follows (in millions):

Consideration Transferred:
Cash paid	$	24.6
Cash acquired	(2.9		)
Contingent consideration	4.0
Total consideration transferred	$	25.7
Allocation of Consideration Transferred:
Accounts receivable	$	3.1
Inventories	6.6
Other current assets	0.3
Property, plant and equipment	2.3
Intangible assets:
Existing technology	7.2
Customer relationships	6.4
Goodwill	10.6
Liabilities assumed	(10.8		)
Total consideration transferred	$	25.7

The fair value allocation includes contingent consideration in the amount of $4.0 million, which represents the estimated fair value of future payments to the former shareholders of the SkyScan business based on achieving annual revenue targets for the years 2012-2014. The maximum potential future payments related to the contingent consideration is capped at approximately $5.9 million. The Company’s allocation of the consideration transferred in connection with the acquisition of the SkyScan business was finalized in the first quarter of 2013 and measurement date adjustments were not material. The weighted-average amortization period for intangible assets acquired in connection with the SkyScan business is 7 years for existing technology and 10 years for customer relationships.

The results of the SkyScan business, including the amount allocated to goodwill, have been included in the Scientific Instruments segment from the date of acquisition.  Pro forma financial information reflecting the acquisition of the SkyScan business has not been presented because the impact on revenues, net income and net income per common share attributable to Bruker Corporation shareholders is not material.